Considering the high rates of incidence and mortality associated with NSCLC, along with previous data showing increased ARPC1A expression in LUAD as well as LUSC (Figures 1A–C), our next objective was to further assess ARPC1A expression levels in NSCLC. Here, ARPC1A is linked to non-small cell lung carcinoma.